Huaren Pharmaceutical Co., Ltd.
300110.SZ
Price:
$3.53
Market Cap:
$4.17B
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. It also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and carbohydrate metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable s...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-08-25
Stock Exchange
SHZ
Ticker
300110.SZ
PE Ratio
[-2.97]
ROE
[-106.15%]
Current Ratio
[0.74]
Dividend Yield
[0%]
Enterprise Value
[5.39B]
Dividend History
The ROE as of December 2025 (TTM) for Huaren Pharmaceutical Co., Ltd. (300110.SZ) is -106.15%
According to Huaren Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -106.15%. This represents a change of 291.46% compared to the average of -27.12% of the last 4 quarters.
Huaren Pharmaceutical Co., Ltd. (300110.SZ) Historical ROE (quarterly & annually)
How has 300110.SZ ROE performed in the past?
The mean historical ROE of Huaren Pharmaceutical Co., Ltd. over the last ten years is -7.19%. The current -106.15% ROE has changed 1.38% with respect to the historical average. Over the past ten years (40 quarters), 300110.SZ's ROE was at its highest in in the January 2023 quarter at 2.27%. The ROE was at its lowest in in the December 2024 quarter at -112.55%.
Average
-7.19%
Median
2.23%
Minimum
-105.20%
Maximum
7.14%
Huaren Pharmaceutical Co., Ltd. (300110.SZ) ROE by Quarter and Year
Discovering the peaks and valleys of Huaren Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 116.69%
Maximum Annual ROE = 7.14%
Minimum Annual Increase = -1607.10%
Minimum Annual ROE = -105.20%
| Year | ROE | Change |
|---|---|---|
| 2024 | -105.20% | -1607.10% |
| 2023 | 6.98% | -2.27% |
| 2022 | 7.14% | 29.89% |
| 2021 | 5.50% | 31.27% |
| 2020 | 4.19% | 116.69% |
| 2019 | 1.93% | 8.68% |
| 2018 | 1.78% | -29.60% |
| 2017 | 2.53% | 54.55% |
| 2016 | 1.63% | 2.70% |
| 2015 | 1.59% | -58.05% |
Huaren Pharmaceutical Co., Ltd. (300110.SZ) Average ROE
How has 300110.SZ ROE performed in the past?
The current ROE of Huaren Pharmaceutical Co., Ltd. (300110.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-30.36%
5-year avg
-16.28%
10-year avg
-7.19%
Huaren Pharmaceutical Co., Ltd. (300110.SZ) ROE vs. Peers
How is 300110.SZ’s ROE compared to its peers?
Huaren Pharmaceutical Co., Ltd.’s ROE is greater than Zhongzhu Healthcare Holding Co.,Ltd (-32.45%), greater than Honz Pharmaceutical Co., Ltd. (-17.26%), greater than Lionco Pharmaceutical Group Co.,Ltd. (-15.83%), less than ZhuZhou QianJin Pharmaceutical Co.,Ltd (10.08%), less than Nanjing Well Pharmaceutical Group Co.,Ltd. (8.53%), less than Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (17.53%), greater than Harbin Medisan Pharmaceutical Co., Ltd. (-9.30%), less than Henan Taloph Pharmaceutical Stock Co.,Ltd (2.96%), less than Tibet AIM Pharm. Inc. (11.20%), less than Jinling Pharmaceutical Company Limited (0.99%),
| Company | ROE | Market cap |
|---|---|---|
| -32.45% | $5.67B | |
| -17.26% | $5.05B | |
| -15.83% | $3.66B | |
| 10.08% | $4.40B | |
| 8.53% | $3.64B | |
| 17.53% | $3.53B | |
| -9.30% | $4.41B | |
| 2.96% | $4.74B | |
| 11.20% | $3.30B | |
| 0.99% | $4.60B |
Build a custom stock screener for Huaren Pharmaceutical Co., Ltd. (300110.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Huaren Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Huaren Pharmaceutical Co., Ltd. (300110.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Huaren Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Huaren Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Huaren Pharmaceutical Co., Ltd. (300110.SZ)?
What is the highest ROE for Huaren Pharmaceutical Co., Ltd. (300110.SZ)?
What is the 3-year average ROE for Huaren Pharmaceutical Co., Ltd. (300110.SZ)?
What is the 5-year average ROE for Huaren Pharmaceutical Co., Ltd. (300110.SZ)?
How does the current ROE for Huaren Pharmaceutical Co., Ltd. (300110.SZ) compare to its historical average?